New Journal, Sexual Medicine Reviews, Will Launch in May
Pelvic Floor Dysfunction, Urinary Incontinence Cause Sexual Problems for Women
The ISSM is pleased to announce the launch of its third professional journal, Sexual Medicine Reviews. The inaugural issue will be published in May.
Sexual Medicine Reviews commissions systematic, evidence-based reviews in the global field of sexual medicine. On a quarterly basis, the journal will synthesize clinical and translational research in order to distill for the widest possible audience of healthcare practitioners the best available evidence in the field, with an emphasis on promoting knowledge translation in sexual health.
The new journal is edited by Culley C. Carson III, MD, the Rhodes Distinguished Professor of Urology and former Chief of Urology at the University of North Carolina.
Sexual Medicine Reviews joins two other publications in the ISSM family of journals: The Journal of Sexual Medicine and the recently-launched open-access journal Sexual Medicine.
Author guidelines for Sexual Medicine Reviews may be found here.
ISSM members are eligible to receive a subscription to Sexual Medicine Reviews as part of their membership. Not a member? Click here to join today!
New Research: Flibanserin and Appetitive Sexual Motivation in the Female Rat
Women who have pelvic organ prolapse (POP) or urinary incontinence can face a host of sexual problems, European researchers report.
Women with these conditions often feel anxious about sex. They may have problems with body image, feel unattractive, and worry about having an accident during intercourse or orgasm. Many are also concerned about their partner's experience.
For the study, the researchers interviewed 37 women between the ages of 31 and 64. The participants were scheduled to have corrective surgery for POP, UI, or both POP and UI at the time of the interview. Questions centered on desire, arousal, orgasm, pain, satisfaction, body image, partners, and intimacy.
Some women explained that they did not feel motivated to have sex. Others rushed through sexual activity or completely avoided it. Some experienced pain. Many felt that they couldn't relax enough to become aroused or reach orgasm.
The authors acknowledged that other factors, aside from POP and UI, can affect a woman's sexual function. However, they also noted that it would help women if healthcare providers explained the potential sexual problems associated with POP and UI.
The study was published online in January in The Journal of Sexual Medicine. For more details, please click here.
A new research summary concerning the drug flibanserin and its effects on female rats has been posted to the ISSM website.
Flibanserin is currently in clinical trials and showing some encouraging results for premenopausal women with hypoactive sexual desire disorder (HSDD).
This study discusses an experiment involving male and female rats.
After being ovariectomized, the females were primed with one of two types of hormonal treatments. Subgroups were then given varying doses of flibanserin.
Next, the females were paired with males. Researchers observed the rats' sexual activity, playing close attention to the ways females encouraged or rejected the males' interest and regulated the timing between sexual encounters. The scientists also observed lordosis, the physical position a female rat assumes so that a male can penetrate her.
Overall, the researchers found that "chronic flibanserin treatment facilitates female sexual motivation, regardless of their hormonal regimen."
Please click here to learn more about this study and here to see other Research Summaries.